Current studies into retatritide peptide demonstrate significant possibility for read more addressing excess body and type 2 diabetes. The compound, a dual agonist of GLP-1 receptor and glucose-dependent insulinotropic polypeptide, looks to provide greater weight loss and glycemic control versus existing medications. Ongoing research efforts are ne